PriceTargets.com logo

Waters - WAT Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $298.67
  • Forecasted Upside: 1.51%
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$294.23 As of 04/18/2024 01:00 AM ET
▼ -9.95 (-3.27%)

This chart shows the closing price for WAT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Waters Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WAT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WAT

Analyst Price Target is $298.67
▲ +1.51% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Waters in the last 3 months. The average price target is $298.67, with a high forecast of $340.00 and a low forecast of $250.00. The average price target represents a 1.51% upside from the last price of $294.23.

This chart shows the closing price for WAT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 polled investment analysts is to reduce stock in Waters. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
10/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
1/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
4/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
7/23/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
10/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
1/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
3/19/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings
Ratings as of
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/4/2024Evercore ISIBoost TargetIn-Line ➝ In-Line$320.00 ➝ $340.00Low
2/12/2024BarclaysBoost TargetUnderweight ➝ Underweight$275.00 ➝ $300.00Low
2/7/2024Stifel NicolausBoost TargetHold ➝ Hold$290.00 ➝ $330.00Low
1/25/2024BarclaysBoost TargetUnderweight ➝ Underweight$230.00 ➝ $275.00Low
12/13/2023Wolfe ResearchInitiated CoveragePeer PerformLow
12/11/2023CitigroupBoost TargetNeutral ➝ Neutral$265.00 ➝ $300.00Low
11/13/2023BarclaysDowngradeEqual Weight ➝ Underweight$270.00 ➝ $230.00Low
11/8/2023Stifel NicolausLower TargetHold ➝ Hold$305.00 ➝ $290.00Low
11/8/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$260.00 ➝ $250.00Low
11/8/2023Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$305.00 ➝ $285.00Low
10/17/2023JPMorgan Chase & Co.Lower TargetNeutral ➝ Neutral$290.00 ➝ $260.00Low
9/29/2023BarclaysLower Target$288.00 ➝ $270.00Low
9/28/2023Sanford C. BernsteinInitiated CoverageMarket Perform$280.00Low
8/3/2023BarclaysBoost TargetEqual Weight ➝ Equal Weight$275.00 ➝ $288.00Low
7/31/2023BarclaysDowngradeOverweight ➝ Equal Weight$275.00Low
6/27/2023BarclaysLower Target$325.00 ➝ $290.00Low
5/10/2023Stifel NicolausLower Target$345.00 ➝ $315.00Low
5/10/2023Bank of AmericaLower Target$350.00 ➝ $315.00Low
5/10/2023Wells Fargo & CompanyLower Target$345.00 ➝ $305.00Low
5/10/2023Robert W. BairdLower Target$345.00 ➝ $288.00Low
5/10/2023BarclaysLower Target$350.00 ➝ $325.00Low
4/4/2023BarclaysLower TargetOverweight$385.00 ➝ $350.00Low
2/16/2023CitigroupBoost TargetNeutral$325.00 ➝ $340.00Low
2/16/2023Wells Fargo & CompanyBoost TargetEqual Weight$320.00 ➝ $345.00Low
2/16/2023Robert W. BairdBoost TargetNeutral$334.00 ➝ $345.00Low
1/24/2023BarclaysBoost TargetOverweight$340.00 ➝ $380.00Low
1/6/2023SVB LeerinkBoost TargetMarket Perform$320.00 ➝ $352.00Low
12/13/2022Deutsche Bank AktiengesellschaftInitiated CoverageHold$350.00Low
11/2/2022Wells Fargo & CompanyBoost TargetEqual Weight$315.00 ➝ $320.00Low
11/2/2022Robert W. BairdLower Target$348.00 ➝ $317.00N/A
11/2/2022SVB LeerinkBoost TargetMarket Perform$310.00 ➝ $320.00Low
10/6/2022BarclaysLower TargetOverweight$345.00 ➝ $340.00Low
9/12/2022BarclaysLower TargetOverweight$375.00 ➝ $345.00Low
8/24/2022Credit Suisse GroupInitiated CoverageNeutral$345.00Low
8/9/2022CowenBoost Target$378.00Low
8/4/2022UBS GroupBoost TargetNeutral$349.00 ➝ $375.00Low
8/3/2022Robert W. BairdBoost Target$340.00 ➝ $348.00Low
7/20/2022UBS GroupInitiated CoverageNeutral$349.00Low
5/20/2022CowenBoost Target$358.00High
5/17/2022BarclaysInitiated CoverageOverweight$375.00Medium
5/17/2022Bank of AmericaUpgradeUnderperform ➝ Neutral$320.00 ➝ $330.00N/A
4/25/2022Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$320.00 ➝ $315.00Low
2/2/2022SVB LeerinkLower TargetMarket Perform$375.00 ➝ $350.00High
8/4/2021SVB LeerinkBoost TargetMarket Perform$370.00 ➝ $385.00Medium
8/4/2021Robert W. BairdBoost TargetNeutral$297.00 ➝ $360.00Medium
8/4/2021CitigroupBoost TargetNeutral$315.00 ➝ $400.00Medium
7/6/2021Evercore ISIUpgradeIn-Line ➝ Outperform$400.00Medium
5/6/2021SVB LeerinkBoost TargetMarket Perform$290.00 ➝ $300.00Low
5/6/2021Wells Fargo & CompanyBoost TargetUnderweight$280.00 ➝ $290.00Low
2/3/2021CitigroupBoost Target$250.00 ➝ $300.00Low
1/7/2021Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$235.00N/A
12/16/2020Smith Barney CitigroupUpgradeSell ➝ NeutralLow
12/2/2020The Goldman Sachs GroupInitiated CoverageNeutral$230.00Low
11/9/2020KeyCorpInitiated CoverageSector Weight ➝ Sector Weight$235.00Medium
10/28/2020Stifel NicolausBoost TargetHold$220.00 ➝ $230.00Medium
10/28/2020Smith Barney CitigroupBoost Target$180.00 ➝ $185.00Low
10/28/2020Wells Fargo & CompanyBoost TargetEqual Weight$230.00 ➝ $235.00Low
10/28/2020SVB LeerinkBoost TargetMarket Perform$225.00 ➝ $230.00Low
7/29/2020Stifel NicolausBoost TargetHold$180.00 ➝ $220.00High
7/29/2020SVB LeerinkBoost TargetMarket Perform$195.00 ➝ $225.00High
7/29/2020CitigroupBoost TargetSell$150.00 ➝ $180.00High
7/28/2020Needham & Company LLCInitiated CoverageSellHigh
7/28/2020JPMorgan Chase & Co.UpgradeUnderweight ➝ NeutralLow
7/16/2020Wells Fargo & CompanyUpgradeUnderweight ➝ Equal Weight$175.00 ➝ $225.00Medium
4/29/2020Bank of AmericaLower TargetUnderperform$160.00 ➝ $145.00High
4/29/2020Stifel NicolausBoost TargetHold$176.00 ➝ $180.00Medium
4/29/2020SVB LeerinkLower TargetMarket Perform$210.00 ➝ $195.00High
4/28/2020Needham & Company LLCInitiated CoverageSellHigh
4/28/2020UBS GroupLower TargetNeutral$223.00 ➝ $212.00Low
4/2/2020Stifel NicolausLower TargetHold$210.00 ➝ $176.00Low
3/30/2020Wells Fargo & CompanyLower TargetUnderweight$210.00 ➝ $180.00Medium
3/26/2020BarclaysLower TargetUnderweight$186.00 ➝ $172.00High
3/20/2020CitigroupLower TargetSell$190.00 ➝ $150.00Medium
2/4/2020Needham & Company LLCReiterated RatingSellHigh
1/8/2020Needham & Company LLCDowngradeHold ➝ UnderperformMedium
1/7/2020Wells Fargo & CompanyInitiated CoverageUnderweight$215.00High
1/6/2020CitigroupInitiated CoverageSell$190.00Medium
1/3/2020Needham & Company LLCInitiated CoverageHold$177.00Medium
1/3/2020Bank of AmericaUpgradeUnderperform ➝ NeutralMedium
12/4/2019BTIG ResearchDowngradeBuy ➝ NeutralLow
11/14/2019Stifel NicolausInitiated CoverageHold$210.00Medium
10/29/2019Needham & Company LLCReiterated RatingHoldHigh
10/9/2019BarclaysDowngradeEqual Weight ➝ Underweight$210.00 ➝ $195.00Low
7/16/2019Bank of AmericaDowngradeNeutral ➝ UnderperformLow
5/30/2019Wolfe ResearchInitiated CoverageUnderperform ➝ UnderperformLow
4/24/2019UBS GroupLower TargetNeutral ➝ Neutral$248.00 ➝ $230.00Low
4/24/2019Robert W. BairdLower TargetNeutral ➝ Neutral$211.00 ➝ $209.00Low
4/24/2019BarclaysLower TargetEqual Weight ➝ Equal Weight$218.00 ➝ $210.00Low
(Data available from 4/18/2019 forward)

News Sentiment Rating

0.15 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 36 very positive mentions
  • 114 positive mentions
  • 34 negative mentions
  • 22 very negative mentions
Mentions as of
9/21/2023
  • 29 very positive mentions
  • 139 positive mentions
  • 44 negative mentions
  • 21 very negative mentions
Mentions as of
10/21/2023
  • 16 very positive mentions
  • 107 positive mentions
  • 44 negative mentions
  • 19 very negative mentions
Mentions as of
11/20/2023
  • 24 very positive mentions
  • 119 positive mentions
  • 31 negative mentions
  • 15 very negative mentions
Mentions as of
12/20/2023
  • 30 very positive mentions
  • 104 positive mentions
  • 36 negative mentions
  • 20 very negative mentions
Mentions as of
1/19/2024
  • 38 very positive mentions
  • 118 positive mentions
  • 32 negative mentions
  • 16 very negative mentions
Mentions as of
2/18/2024
  • 42 very positive mentions
  • 114 positive mentions
  • 22 negative mentions
  • 13 very negative mentions
Mentions as of
3/19/2024
  • 33 very positive mentions
  • 113 positive mentions
  • 34 negative mentions
  • 15 very negative mentions
Mentions as of
4/18/2024

Current Sentiment

  • 33 very positive mentions
  • 113 positive mentions
  • 34 negative mentions
  • 15 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Waters logo
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
Read More

Today's Range

Now: $294.23
Low: $288.94
High: $300.40

50 Day Range

MA: $336.42
Low: $294.23
High: $361.00

52 Week Range

Now: $294.23
Low: $231.90
High: $363.80

Volume

687,005 shs

Average Volume

407,500 shs

Market Capitalization

$17.45 billion

P/E Ratio

27.12

Dividend Yield

N/A

Beta

0.92

Frequently Asked Questions

What sell-side analysts currently cover shares of Waters?

The following Wall Street sell-side analysts have issued stock ratings on Waters in the last twelve months: Bank of America Co., Barclays PLC, Citigroup Inc., Evercore ISI, JPMorgan Chase & Co., Robert W. Baird, Sanford C. Bernstein, Stifel Nicolaus, StockNews.com, TheStreet, Wells Fargo & Company, and Wolfe Research.
View the latest analyst ratings for WAT.

What is the current price target for Waters?

9 Wall Street analysts have set twelve-month price targets for Waters in the last year. Their average twelve-month price target is $298.67, suggesting a possible upside of 1.5%. Evercore ISI has the highest price target set, predicting WAT will reach $340.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $250.00 for Waters in the next year.
View the latest price targets for WAT.

What is the current consensus analyst rating for Waters?

Waters currently has 1 sell rating and 7 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for WAT.

What other companies compete with Waters?

Other companies that are similar to Waters include Illumina, Bio-Rad Laboratories, Avantor, Revvity and Bio-Rad Laboratories. Learn More about companies similar to Waters.

How do I contact Waters' investor relations team?

Waters' physical mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier's listed phone number is (508) 478-2000 and its investor relations email address is [email protected]. The official website for Waters is www.waters.com. Learn More about contacing Waters investor relations.